AD504
/ Apnimed
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
August 12, 2022
MARIPOSA: Parallel Arm Trial of AD109 and AD504 In Patients With OSA
(clinicaltrials.gov)
- P2 | N=294 | Completed | Sponsor: Apnimed | Active, not recruiting ➔ Completed
Trial completion • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
June 10, 2022
MARIPOSA: Parallel Arm Trial of AD109 and AD504 In Patients With OSA
(clinicaltrials.gov)
- P2 | N=280 | Active, not recruiting | Sponsor: Apnimed | Recruiting ➔ Active, not recruiting
Enrollment closed • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
December 07, 2021
MARIPOSA: Parallel Arm Trial of AD109 and AD504 In Patients With OSA
(clinicaltrials.gov)
- P2; N=280; Recruiting; Sponsor: Apnimed; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
November 16, 2021
Apnimed Achieves Meaningful Results in Proof-of-Concept Crossover Study With Oral Therapeutic Candidates AD504 and AD182 for the Treatment of Obstructive Sleep Apnea
(Businesswire)
- P2, N=15; NCT04645524; Sponsor: Apnimed; "Apnimed...announced positive topline results from a proof-of-concept randomized, controlled, double-blind, single-dose, three-period crossover study (protocol APX-001) in patients with OSA evaluating AD504 and AD182...AD504 showed a strong trend in reduction of AHI from placebo (from 18.2[11.8-31.3] events/hour to 7.4[5.4-16.1] events/hour, p=0.06) and a significant reduction in HB from placebo (from 48.2[31.2-79.6] to 18.7[14.9-43.5] %min/hour, p<0.001). AD182 also demonstrated a trend towards reduction in HB relative to placebo."
P2 data • CNS Disorders • Obstructive Sleep Apnea • Sleep Disorder
October 08, 2021
MARIPOSA: Parallel Arm Trial of AD109 and AD504 In Patients With OSA
(clinicaltrials.gov)
- P2; N=280; Not yet recruiting; Sponsor: Apnimed
Clinical • New P2 trial • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
September 02, 2021
Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
(clinicaltrials.gov)
- P2; N=15; Completed; Sponsor: Apnimed; Recruiting ➔ Completed
Clinical • Trial completion • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
1 to 6
Of
6
Go to page
1